Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency (MHRA) said on Tuesday it had approved Merck's MRK.N therapy, sotatercept, to treat a rare lung condition.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil D'Silva)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))